Announcement on Outline of the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
The briefing took place via an online interactive format, allowing for investor engagement. The company addressed various investor inquiries regarding its product offerings and sales strategies. Topics included the presence of skincare products and the company's sub-brands. The announcement expresses gratitude to investors for their ongoing support and suggestions.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai No. 1 Pharmacy Co. Ltd. on 6ix
Earlier from Shanghai No. 1 Pharmacy
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
- Report for Q3 2025
- Announcement on Proposed Signing of Housing Expropriation Compensation Agreement by the Wholly-owned Subsidiary
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
Later from Shanghai No. 1 Pharmacy
- Earnings Preannouncement for 2025
- Announcement on Resolutions of the 8th (Extraordinary) Meeting of the 11th Board of Directors
- Announcement on Renewal of Engagement with Financial Report Audit Accounting Firm
- Announcement on Progress in Receiving the Expropriation Compensation for Housing by the Wholly-owned Subsidiary
- Announcement on Operating Data for Q1 2026
Follow Shanghai No. 1 Pharmacy into a list and get an email when it puts out news.
Follow Shanghai No. 1 Pharmacy